BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10154655)

  • 1. Consumer information surplus and adverse selection in competitive health insurance markets: an empirical study.
    van de Ven WP; van Vliet RC
    J Health Econ; 1995 Jun; 14(2):149-69. PubMed ID: 10154655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse selection with a multiple choice among health insurance plans: a simulation analysis.
    Marquis MS
    J Health Econ; 1992 Aug; 11(2):129-51. PubMed ID: 10122975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deductibles in health insurance: can the actuarially fair premium reduction exceed the deductible?
    Bakker FM; van Vliet RC; van de Ven WP
    Health Policy; 2000 Sep; 53(2):123-41. PubMed ID: 10958993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased selection in the Federal Employees Health Benefits Program.
    Price JR; Mays JW
    Inquiry; 1985; 22(1):67-77. PubMed ID: 2933333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal non-linear health insurance.
    Blomqvist A
    J Health Econ; 1997 Jun; 16(3):303-21. PubMed ID: 10169303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health insurance under competition: would people choose what is expected?
    Hershey JC; Kunreuther H; Schwartz JS; Williams SV
    Inquiry; 1984; 21(4):349-60. PubMed ID: 6240466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?
    van Winssen KP; van Kleef RC; van de Ven WP
    Eur J Health Econ; 2017 Mar; 18(2):209-226. PubMed ID: 26857921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?
    van de Ven WP; van Vliet RC; Schut FT; van Barneveld EM
    J Health Econ; 2000 May; 19(3):311-39. PubMed ID: 10977194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worker demand for health insurance in the non-group market: a note on the calculation of welfare loss.
    Chernew M; Frick K; McLaughlin CG
    J Health Econ; 1997 Jun; 16(3):375-80. PubMed ID: 10169307
    [No Abstract]   [Full Text] [Related]  

  • 12. A simultaneous equations model of employer strategies for controlling health benefit costs.
    Gifford G; Feldman R; Dowd B; Finch M
    Inquiry; 1991; 28(1):56-66. PubMed ID: 1826497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual insurance: health insurers try to tap potential market growth.
    November EA; Cohen GR; Ginsburg PB; Quinn BC
    Res Brief; 2009 Nov; (14):1-8. PubMed ID: 19899193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential premium range of risk-rating in competitive markets for supplementary health insurance.
    Paolucci F; Prinsze F; Stam PJ; van de Ven WP
    Int J Health Care Finance Econ; 2009 Sep; 9(3):243-58. PubMed ID: 19125326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key role of health insurance in a cost-effective health care system. Towards regulated competition in the Dutch medical market.
    van de Ven WP
    Health Policy; 1987 Apr; 7(2):253-72. PubMed ID: 10312077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Price elasticity and adverse selection in the demand for supplementary health insurance.
    Marquis MS; Phelps CE
    Econ Inq; 1987 Apr; 25(2):299-313. PubMed ID: 10281607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bonus systems in health insurance: a microeconomic analysis.
    Zweifel P
    Health Policy; 1987 Apr; 7(2):273-88. PubMed ID: 10282265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and the competitive standing of health plans in a multiple-choice, multiple-insurer market.
    Price JR; Mays JW
    Adv Health Econ Health Serv Res; 1985; 6():127-47. PubMed ID: 10280618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Must adverse selection cause premium spirals?
    Feldman R; Dowd B
    J Health Econ; 1991 Oct; 10(3):349-57. PubMed ID: 10114571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.